Smoking Cessation and Cardiovascular Disease Risk Factors: Results from the Third National Health and Nutrition Examination Survey
暂无分享,去创建一个
[1] E. Fleck,et al. C-Reactive Protein Induces Apoptosis in Human Coronary Vascular Smooth Muscle Cells , 2004, Circulation.
[2] L. Appel,et al. Relationship between systemic markers of inflammation and serum beta-carotene levels. , 2001, Archives of internal medicine.
[3] N J Wald,et al. Environmental tobacco smoke exposure and ischaemic heart disease: an evaluation of the evidence , 1997, BMJ.
[4] J. L. Harrison,et al. The Government Printing Office , 1968, American Journal of Pharmaceutical Education.
[5] S. Verma,et al. Biomarkers of Vascular Disease Linking Inflammation to Endothelial Activation: Part II , 2003, Circulation.
[6] J. Danesh,et al. Low grade inflammation and coronary heart disease: prospective study and updated meta-analyses , 2000, BMJ : British Medical Journal.
[7] Ratnam,et al. The regulation of superoxide generation and nitric oxide synthesis by C‐reactive protein , 1998, Immunology.
[8] D. Cook,et al. GIVING UP SMOKING AND THE RISK OF HEART ATTACKS A report from The British Regional Heart Study , 1986, The Lancet.
[9] P. Vallance,et al. Infection, inflammation, and infarction: does acute endothelial dysfunction provide a link? , 1997, The Lancet.
[10] Jing Ma,et al. Inflammatory markers and the risk of coronary heart disease in men and women. , 2004, The New England journal of medicine.
[11] P. Ridker,et al. C-reactive protein, subclinical atherosclerosis, and risk of cardiovascular events. , 2002, Arteriosclerosis, thrombosis, and vascular biology.
[12] J. Volanakis,et al. Molecular genetics, structure, and function of C-reactive protein , 1991, Immunologic research.
[13] Jiang He,et al. Relationship between Cigarette Smoking and Novel Risk Factors for Cardiovascular Disease in the United States , 2003, Annals of Internal Medicine.
[14] A. C. Robertson,et al. DESIGN AND USE OF PLASTIC TENTS FOR ISOLATION OF PATIENTS PRONE TO INFECTION , 1968 .
[15] N. Rigotti,et al. Cigarette smoking and coronary heart disease: risks and management. , 1996, Cardiology clinics.
[16] M. Kutryk,et al. C-Reactive Protein Attenuates Endothelial Progenitor Cell Survival, Differentiation, and Function: Further Evidence of a Mechanistic Link Between C-Reactive Protein and Cardiovascular Disease , 2004, Circulation.
[17] Å. Westin,et al. Effect of smoking reduction and cessation on cardiovascular risk factors. , 2001, Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco.
[18] Ren-Ke Li,et al. A Self-Fulfilling Prophecy: C-Reactive Protein Attenuates Nitric Oxide Production and Inhibits Angiogenesis , 2002, Circulation.
[19] D. Panagiotakos,et al. Effect of exposure to secondhand smoke on markers of inflammation: the ATTICA study. , 2004, The American journal of medicine.
[20] François Mach,et al. Inflammation and Atherosclerosis , 2004, Herz.
[21] P. Mendola,et al. Blood lead levels and sexual maturation in U.S. girls: the Third National Health and Nutrition Examination Survey, 1988-1994. , 2003, Environmental health perspectives.
[22] T. Meade,et al. Fibrinolytic activity, clotting factors, and long-term incidence of ischaemic heart disease in the Northwick Park Heart Study , 1993, The Lancet.
[23] N. Rifai. C-reactive protein and coronary heart disease , 2007, Cardiovascular Toxicology.
[24] J. Deckers,et al. Registration and management of smoking behaviour in patients with coronary heart disease. The EUROASPIRE survey. , 1999, European heart journal.
[25] R Peto,et al. Association of fibrinogen, C-reactive protein, albumin, or leukocyte count with coronary heart disease: meta-analyses of prospective studies. , 1998, JAMA.
[26] G. Lozanski,et al. Do Post‐transcriptional Mechanisms Participate in Induction of C‐reactive Protein and Serum Amyloid A by IL‐6 and IL‐I? a , 1995, Annals of the New York Academy of Sciences.
[27] L. Kuller,et al. Relation of C-reactive protein and coronary heart disease in the MRFIT nested case-control study. Multiple Risk Factor Intervention Trial. , 1996, American journal of epidemiology.
[28] N. Benowitz. Cigarette smoking and cardiovascular disease: pathophysiology and implications for treatment. , 2003, Progress in cardiovascular diseases.
[29] A. Döring,et al. C-Reactive protein, a sensitive marker of inflammation, predicts future risk of coronary heart disease in initially healthy middle-aged men: results from the MONICA (Monitoring Trends and Determinants in Cardiovascular Disease) Augsburg Cohort Study, 1984 to 1992. , 1999, Circulation.
[30] Meinders Ae,et al. [Atherosclerosis and inflammation: the role of C-reactive protein]. , 2003 .
[31] S. Johansson,et al. Cessation of smoking after myocardial infarction. Effects on mortality after 10 years. , 1983, British heart journal.
[32] V. Poli,et al. Interleukin-6 is necessary, but not sufficient, for induction of the humanC-reactive protein gene in vivo. , 1997, The Biochemical journal.
[33] M. Visser,et al. Elevated C-reactive protein levels in overweight and obese adults. , 1999, JAMA.
[34] James T. Willerson,et al. Modulation of C-Reactive Protein-Mediated Monocyte Chemoattractant Protein-1 Induction in Human Endothelial Cells by Anti-Atherosclerosis Drugs , 2001, Circulation.
[35] S. Thompson,et al. Hemostatic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris. European Concerted Action on Thrombosis and Disabilities Angina Pectoris Study Group. , 1995, The New England journal of medicine.
[36] T. Strandberg,et al. C-reactive protein, cardiovascular risk factors, and mortality in a prospective study in the elderly. , 2000, Arteriosclerosis, thrombosis, and vascular biology.
[37] A. Agrawal,et al. Overexpressed nuclear factor‐κB can participate in endogenous C‐reactive protein induction, and enhances the effects of C/EBPβ and signal transducer and activator of transcription‐3 , 2003, Immunology.
[38] L. Kuller,et al. Lifetime smoking exposure affects the association of C-reactive protein with cardiovascular disease risk factors and subclinical disease in healthy elderly subjects. , 1997, Arteriosclerosis, thrombosis, and vascular biology.
[39] T. Meade,et al. EFFECTS OF CHANGES IN SMOKING AND OTHER CHARACTERISTICS ON CLOTTING FACTORS AND THE RISK OF ISCHAEMIC HEART DISEASE , 1987, The Lancet.
[40] V. Hombach,et al. C-Reactive Protein–Mediated Low Density Lipoprotein Uptake by Macrophages: Implications for Atherosclerosis , 2001, Circulation.
[41] P. Mcgeer,et al. Generation of C-reactive protein and complement components in atherosclerotic plaques. , 2001, The American journal of pathology.
[42] A. Dobson,et al. How soon after quitting smoking does risk of heart attack decline? , 1991, Journal of clinical epidemiology.
[43] S. Glantz,et al. Short-term economic and health benefits of smoking cessation: myocardial infarction and stroke. , 1997, Circulation.
[44] M. Szklo,et al. Active and passive smoking are associated with increased carotid wall thickness. The Atherosclerosis Risk in Communities Study. , 1994, Archives of internal medicine.
[45] S. Thompson,et al. Production of C-reactive protein and risk of coronary events in stable and unstable angina , 1997, The Lancet.
[46] Plan and operation of the Third National Health and Nutrition Examination Survey, 1988-94. Series 1: programs and collection procedures. , 1994, Vital and health statistics. Ser. 1, Programs and collection procedures.
[47] E. Falk,et al. Pathology of the Coronary Arteries in Smokers and Non-Smokers , 1999, Journal of cardiovascular risk.
[48] Nancy R Cook,et al. Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events. , 2002, The New England journal of medicine.
[49] R. Kronmal,et al. The temporal pattern of reduction of mortality risk after smoking cessation. , 1990, American Journal of Preventive Medicine.
[50] Global tobacco treaty enters into force with 57 countries already committed. , 2005, Indian journal of medical sciences.
[51] J. Danesh,et al. Risk factors for coronary heart disease and acute-phase proteins. A population-based study. , 1999, European heart journal.
[52] Ose,et al. Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events* , 2002 .
[53] R. Frye,et al. T-Cell–Mediated Lysis of Endothelial Cells in Acute Coronary Syndromes , 2002, Circulation.
[54] W. Sluiter,et al. Association of plasma fibrinogen levels with coronary artery disease, smoking and inflammatory markers. , 1996, Atherosclerosis.
[55] J. Borensztajn,et al. Macrophage uptake of low-density lipoprotein bound to aggregated C-reactive protein: possible mechanism of foam-cell formation in atherosclerotic lesions. , 2002, The Biochemical journal.
[56] S. Chakraborti,et al. Complement activation in heart diseases. Role of oxidants. , 2000, Cellular signalling.
[57] J. Mackeith. DISCHARGE OF VIOLENT PATIENTS , 1975, The Lancet.
[58] A. Meinders,et al. [Atherosclerosis and inflammation: the role of C-reactive protein]. , 2003, Nederlands tijdschrift voor geneeskunde.
[59] N. Cook,et al. C-reactive protein and coronary heart disease. , 2004, The New England journal of medicine.
[60] Neil R. Powe,et al. The Atherosclerosis Risk in Communities Study , 2006 .
[61] T. Pechacek,et al. How acute and reversible are the cardiovascular risks of secondhand smoke? , 2004, BMJ : British Medical Journal.
[62] T. Pearson. New Tools for Coronary Risk Assessment: What Are Their Advantages and Limitations? , 2002, Circulation.
[63] J. Manson,et al. Inflammatory biomarkers, hormone replacement therapy, and incident coronary heart disease: prospective analysis from the Women's Health Initiative observational study. , 2002, JAMA.
[64] S. Leeder,et al. A population based study , 1993, The Medical journal of Australia.
[65] S. Shapiro,et al. Decline in the risk of myocardial infarction among women who stop smoking. , 1990, The New England journal of medicine.
[66] D. Mannino,et al. Serum carotenoid concentrations in US children and adolescents. , 2002, The American journal of clinical nutrition.
[67] A. Agrawal,et al. The Rel Family Member P50 Mediates Cytokine-Induced C-Reactive Protein Expression by a Novel Mechanism1 , 2000, The Journal of Immunology.